AngioWaveNet vs Cleerly LABS
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization laboratory aims to enhance real-time or near real-time fluoroscopic angiograms for improved vessel visualization during interventional procedures. This tool is ideal for seamless integration into existing cath lab workflows, providing immediate AI-powered post-processing to aid interventional cardiologists in complex cases, regardless of the angiography system vendor.
View AngioWaveNet →Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, non-invasive AI-powered analysis of coronary CT angiography (CCTA) for detailed plaque assessment and personalized heart disease management. This solution is best suited for diagnosing, quantifying, and characterizing atherosclerosis and stenosis, as well as tracking disease progression over time to inform long-term patient care strategies.
View Cleerly LABS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Cleerly LABS |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Per analysis |
| Deployment | Cloud-based or on-premise/servers | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet is designed for seamless integration into existing Cath lab workflows and is compatible with any fluoroscopic angiography system, making it vendor-agnostic. Its post-processing nature means minimal disruption to image acquisition, and it requires only minimal training for staff, suggesting high ease of adoption and use.
Clinical Value
Cleerly LABSWhile AngioWaveNet enhances real-time visualization during procedures, Cleerly LABS offers a more comprehensive diagnostic and prognostic clinical value. It provides detailed quantification and characterization of coronary plaque, stenosis detection, and ischemia assessment from CCTA, which is crucial for personalized heart disease management and tracking disease progression.
Pricing & Value
AngioWaveNetAngioWaveNet offers flexible enterprise-level pricing, including annual software licensing or subscription-based access tailored to hospital volume, which provides predictable budgeting. Cleerly LABS' per-analysis model, with a high retail price and potential out-of-pocket costs for patients, may create financial barriers and administrative complexities for hospitals, especially given CMS billing restrictions.
Enterprise Readiness
AngioWaveNetBoth tools are FDA-cleared and HIPAA compliant, demonstrating foundational readiness. However, AngioWaveNet's flexibility in offering both cloud-based and on-premise deployment options, coupled with its vendor-agnostic compatibility and DICOM endpoint functionality, provides greater adaptability for diverse hospital IT environments and data governance policies.
Innovation
Cleerly LABSAngioWaveNet's AI-powered spatiotemporal enhancement for real-time angiograms is innovative for procedural guidance. However, Cleerly LABS represents a more transformative innovation by providing a comprehensive, quantitative analysis of CCTA for plaque characterization and disease progression, aiming to redefine the approach to heart disease diagnosis and prevention.
Support & Docs
Cleerly LABSCleerly LABS explicitly outlines a structured support system, including dedicated Client Support with specified operating hours (M-F, 10 am-6 pm ET) and specialized IT integration assistance from a Solution Architect team. While AngioWaveNet offers comprehensive onboarding and training, Cleerly's detailed support structure suggests a more robust and readily accessible ongoing support system.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Cleerly LABS |
|---|---|---|
| Primary Application/Focus | AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. |
| Target Imaging Modality | Fluoroscopic angiograms | Coronary CT angiography (CCTA) |
| Integration | Integrates with existing Cath lab workflows; Functions as a DICOM endpoint for imaging systems. | Integration with PACS, RIS, EHR via Cleerly Proxy |
| Key Output/Benefit | Improved vessel visualization in fluoroscopic angiograms; Enhances visibility of blood vessels, vascular structures, and anatomical features. | Comprehensive coronary plaque assessment (volume, type); Stenosis detection and quantification; Personalized heart disease risk assessment; Tracking disease progression over time. |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring AngioWaveNet or Cleerly LABS
Backers
Who funded each tool's parent company.